Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
about
The ketogenic diet as a treatment paradigm for diverse neurological disordersKetogenic diet in neuromuscular and neurodegenerative diseasesReceptor for advanced glycation end products and its involvement in inflammatory diseasesAlzheimer mechanisms and therapeutic strategiesThe Rationale for Insulin Therapy in Alzheimer's DiseaseAlzheimer's Disease: Mechanism and Approach to Cell TherapyFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesCurcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseFood Processing and the Mediterranean DietThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationTransient dynamics of Aβ contribute to toxicity in Alzheimer's diseaseInteraction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsAdvanced glycation endproducts interfere with adhesion and neurite outgrowthAGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neuronsLifestyle and clinical determinants of skin autofluorescence in a population-based cohort studyMechanisms underlying inflammation in neurodegenerationThe hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure.Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors.P21-activated kinase in inflammatory and cardiovascular disease.Radix Achyranthis Bidentatae improves learning and memory capabilities in ovariectomized rats.Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's diseaseRole of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapiesFeatures of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent.Diabetes and cognitionAdvanced glycation end product level, diabetes, and accelerated cognitive aging.Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species.Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitroThe association of diabetes and dementia and possible implications for nondiabetic populations.Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced ratsGlucose indices are associated with cognitive and structural brain measures in young adults.Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.Antiglycation and Antioxidant Properties of Momordica charantiaAn advanced glycation end product (AGE)-receptor for AGEs (RAGE) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function.Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuationsGlucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential
P2860
Q21129287-20508CB8-61F4-4AF5-A62A-D3CB59380B58Q21284703-41DFBFCD-79DD-422E-B6CC-553847330193Q21285070-B51DB76C-423E-468E-AA3B-EF192F102DF4Q22252311-374DEA84-FD77-44E7-8CE5-E05A7D7B8306Q26744834-312658A9-0C8F-4248-93E3-57785B598E28Q26778149-A2D33487-8641-414A-87B2-63F1E78DB580Q26779933-9022E746-6ABF-4551-9DAB-FF9B803164C7Q26781090-DC9EF580-108E-473A-B960-8C3B334F88EAQ26782234-546B5D8F-9BF1-4042-B7CC-E457F0FE2782Q26823454-A89F876A-9F50-4EA1-8A62-08AE8B418359Q26827421-959E385C-2538-4A40-9DF0-0536DBF9E207Q27001177-09FDD85A-CFE5-4917-B673-690099FD9C36Q28544858-6CE3E724-A86A-44BA-929C-920390425271Q28572264-6D87B3A9-68E6-4042-8EB1-64AF5A8AD1FDQ28595700-358E77D4-2AA2-48C2-8754-1D880A8BC7FBQ29617977-6F8A6D42-2D6C-4A1D-A35D-4CDAA610F493Q30372854-AE562F17-D372-4129-9900-965A549C291CQ30426453-6E58C9DF-0F61-432F-94FC-9DFF573D216FQ30578167-315D527F-228D-41ED-B1AB-2835CC31566EQ33887359-381F9F2B-70ED-49F1-9FEA-607C9D6C4EABQ33968271-5B511BD2-EE9D-4399-AC0F-BA3FE18420DDQ34032604-09AA39C7-E92B-46DF-92C8-F782F09D8376Q34094560-D6F76E2F-221B-4BA1-9F30-2B051E70B553Q34260323-115F453F-5103-438D-BEC7-3188EF8AF134Q34299120-9778E0D5-8AC2-4909-B6F1-E1C45EB50F0EQ34974167-24597ACF-0F87-44CD-A59D-03F0AE439D8AQ35162073-E929F38A-0416-4A4C-9D8A-2A99EA0F7E11Q35183396-B0890597-D00F-4D45-B9A3-6425848F3C42Q35207601-6C8C71A0-D69B-4562-9852-B0B748AF192BQ35240099-EE371A7D-8B6E-4DC8-A88A-F10400B47CFAQ35261440-E6F0ADB6-2335-474E-B8C9-DBAEEE37A331Q35594977-CD4338A3-DCDB-4673-A45F-0E081F35FB8BQ35619553-0144572E-07EA-4DEA-9450-BFA4B3B2E50AQ35675132-297BD931-9696-4167-97A6-4DFC26286922Q35730940-9F6D2A35-4C56-4AF7-8E2D-E0305085910FQ35838027-F56FEBF8-6D67-403F-8278-193412BCB99AQ36101386-953EE237-EEE5-4D50-B8EE-DF46F998B8FCQ36492859-76265E14-F983-421E-BDB3-2B8DBB4A07DCQ36860684-2EC410E7-306A-4B03-BE94-922829D3F895Q36913552-EB65EB81-B8E1-4C88-99E8-887E7B69AA0D
P2860
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@ast
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@en
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@nl
type
label
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@ast
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@en
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@nl
prefLabel
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@ast
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@en
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
@nl
P2093
P1476
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
@en
P2093
Annette Maczurek
Bernadette Westcott
Damian Juskiw
Gerald Münch
Thanh Phan
P304
P356
10.1016/J.NEUROBIOLAGING.2009.04.016
P577
2009-05-22T00:00:00Z